HILLSBOROUGH, NJ / ACCESSWIRE / May 28, 2017 / Bionical, a partner to the pharmaceutical and biotech industries, is pleased to announce that Andy Woolf, CEO, US has been named to PM360's 2017 Elite ...

LONDON, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Bionical Emas (“Bionical”) or (“the Company”), the Early Access Programs and Clinical Trial Supply business, is selling its Clinical Development division, ...

LONDON, UK – 29 May 2025: Bionical Emas, a global provider of Clinical Trial Services, announces an exclusive global clinical trial supply agreement with Pharma Resources GmbH, German pharmaceutical ...

Emas Pharma, a CRO that provides biopharma and medical device services, has been bought by outsourced specialist Bionical and joined the latter’s existing clinical services business. Founded in 1998 ...

Willington, UK, June 19, 2024 – Bionical Solutions, a leading provider of technology enabled engagement and healthcare services to global pharmaceutical, biotech, healthcare companies and the NHS, ...

SMi Reports: Interview excerpt with Bionical EMAS’ Executive VP, Tom Watson released for SMi’s 9th Annual Conference on Orphan Drugs & Rare Diseases, in London in less than 3 weeks With less than 3 ...

WILLINGTON, England, June 27, 2024 /PRNewswire/ -- Bionical Solutions, a leading provider of technology enabled engagement and healthcare services to global pharmaceutical, biotech, healthcare ...

Bionical Emas to further strengthen its position as a market leader in Early Access Programs and Clinical Trial Supply The Company will invest in global expansion and further specialised services to ...

WILLINGTON, England, June 19, 2024 /PRNewswire/ -- Bionical Solutions, a leading provider of technology enabled engagement and healthcare services to global pharmaceutical, biotech, healthcare ...